Spero Health - Connersville

Spero Health - Connersville is an addiction-treatment facility located in Lexington, KY. The facility's programming is outpatient (Outpatient, MAT), not residential. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at Spero Health - Connersville

The care-level question matters because what a facility offers is what it can realistically treat well. Spero Health - Connersville is an outpatient-focused program (Outpatient, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether Spero Health - Connersville's offerings match the clinical need.

Insurance and payment

Spero Health - Connersville accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Specialty programming

The facility's documented specialty programming includes: Adult women, Pregnant/postpartum women, Adult men. Specialty programming varies substantially by facility — some facilities offer "dual diagnosis" as a marketing category but not a clinical differentiator. Ask for the specific clinical-team credentials and the actual hours of specialty-specific content per week.

Before you call

Three questions to put to Spero Health - Connersville before admission: the specific ASAM level the facility is billing; the written Verification of Benefits for your specific plan product; the MAT policy (continuation of buprenorphine or methadone during residential, specifically). The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. Getting answers in writing protects against the downstream surprises.